BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9636613)

  • 1. FK506 rescue therapy in lung transplantation.
    Wiebe K; Harringer W; Franke U; Strüber M; Krug N; Korff F; Wahlers T; Cremer J; Haverich A
    Transplant Proc; 1998 Jun; 30(4):1508-9. PubMed ID: 9636613
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical use and bioavailability of tacrolimus in heart-lung and double lung transplant recipients with cystic fibrosis.
    Walker S; Habib S; Rose M; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1519-20. PubMed ID: 9636618
    [No Abstract]   [Full Text] [Related]  

  • 3. Azathioprine withdrawal in stable lung and heart/lung recipients receiving cyclosporine-based immunosuppression.
    Hoffmeyer F; Hoeper MM; Spiekerkötter E; Harringer W; Haverich A; Fabel H; Niedermeyer J
    Transplantation; 2000 Aug; 70(3):522-5. PubMed ID: 10949197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo.
    Nair RV; Huang X; Shorthouse R; Adams B; Brazelton T; Braun-Dullaeus R; Morris RE
    Transplant Proc; 1997; 29(1-2):614-5. PubMed ID: 9123154
    [No Abstract]   [Full Text] [Related]  

  • 5. FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases.
    Knoop C; Antoine M; Vachiéry JL; Yernault JC; Estenne M
    Transplant Proc; 1994 Dec; 26(6):3240-1. PubMed ID: 7527957
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary rejection diagnosis after lung and heart-lung transplantation.
    Reichenspurner H; Dienemann H; Rihl M; Wagner F; Meiser BM; Kur F; Hammer C; Forst H; Kreuzer E; Reichart B
    Transplant Proc; 1993 Dec; 25(6):3299-300. PubMed ID: 8266550
    [No Abstract]   [Full Text] [Related]  

  • 7. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
    Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservation of small-airway function by tacrolimus/cyclosporine conversion in the management of bronchiolitis obliterans following lung transplantation.
    Revell MP; Lewis ME; Llewellyn-Jones CG; Wilson IC; Bonser RS
    J Heart Lung Transplant; 2000 Dec; 19(12):1219-23. PubMed ID: 11124493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus (FK506) proves superior to OKT3 for treating episodes of persistent rejection following intrathoracic transplantation.
    Meiser BM; Uberfuhr P; Schulze C; Fuchs A; Mair H; Reichenspurner H; Kreuzer E; Reichart B
    Transplant Proc; 1997; 29(1-2):605-6. PubMed ID: 9123150
    [No Abstract]   [Full Text] [Related]  

  • 10. Tacrolimus-based immunosuppressive protocols in lung transplantation.
    Reichenspurner H; Kur F; Treede H; Meiser BM; Welz A; Vogelmeier C; Schwaiblmeier M; Müller C; Fürst H; Briegel J; Reichart B
    Transplant Proc; 1999; 31(1-2):171-2. PubMed ID: 10083062
    [No Abstract]   [Full Text] [Related]  

  • 11. Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation.
    Gerbase MW; Spiliopoulos A; Fathi M; Nicod LP
    Transplant Proc; 2001 May; 33(3):2146-7. PubMed ID: 11377481
    [No Abstract]   [Full Text] [Related]  

  • 12. First experience with FK 506 for treatment of chronic pulmonary rejection.
    Reichenspurner H; Meiser BM; Kur F; Wagner F; Welz A; Uberfuhr P; Briegel H; Reichart B
    Transplant Proc; 1995 Jun; 27(3):2009. PubMed ID: 7540775
    [No Abstract]   [Full Text] [Related]  

  • 13. Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation.
    Lipson DA; Palevsky HI; Kotloff RM; Edelman J
    Transplant Proc; 1998 Jun; 30(4):1505-7. PubMed ID: 9636612
    [No Abstract]   [Full Text] [Related]  

  • 14. FK506 for primary and rescue therapy following liver transplantation.
    Platz KP; Mueller AR; Zytowski M; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study.
    Celik MR; Lederer DJ; Wilt J; Eser D; Bacchetta M; D'Ovidio F; Sonett JR; Arcasoy SM
    J Heart Lung Transplant; 2009 Jul; 28(7):697-703. PubMed ID: 19560698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results of rescue therapy with tacrolimus and mycophenolate mofetil in lung transplanted patients with bronchiolitis obliterans.
    Roman A; Bravo C; Monforte V; Reyes L; Canela M; Morell F
    Transplant Proc; 2002 Feb; 34(1):146-7. PubMed ID: 11959227
    [No Abstract]   [Full Text] [Related]  

  • 17. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome.
    Kesten S; Chaparro C; Scavuzzo M; Gutierrez C
    J Heart Lung Transplant; 1997 Sep; 16(9):905-12. PubMed ID: 9322139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation.
    Sarahrudi K; Carretta A; Wisser W; Senbaklavaci O; Ploner M; Neuhauser P; Dobrovits M; Miwai Marta G; Papp A; Klepetko W
    Transpl Int; 2002 Jan; 15(1):24-8. PubMed ID: 11875609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial of FK506 in heart transplant patients in Taiwan: report of 7 cases with immunosuppression switch from cyclosporine to FK506.
    Ko WJ; Chou NK; Chen YS; Hsu RB; Wang SS; Chu SH
    Transplant Proc; 1998 Nov; 30(7):3339-41. PubMed ID: 9838474
    [No Abstract]   [Full Text] [Related]  

  • 20. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
    Treede H; Glanville AR; Klepetko W; Aboyoun C; Vettorazzi E; Lama R; Bravo C; Knoop C; Aubert JD; Reichenspurner H;
    J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.